Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

489 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Feasibility and tolerability of trofosfamide and etoposide in progressive glioblastoma.
Schmidt T, Agkatsev S, Feldheim J, Oster C, Blau T, Sure U, Keyvani K, Kleinschnitz C, Stuschke M, Herrmann K, Deuschl C, Scheffler B, Kebir S, Glas M, Lazaridis L. Schmidt T, et al. Among authors: kleinschnitz c. Neurooncol Adv. 2023 Jul 20;5(1):vdad090. doi: 10.1093/noajnl/vdad090. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 37547266 Free PMC article.
Corneal confocal microscopy identifies corneal nerve loss and increased Langerhans cells in presymptomatic carriers and patients with hereditary transthyretin amyloidosis.
Thimm A, Carpinteiro A, Oubari S, Papathanasiou M, Kessler L, Rischpler C, Malik RA, Herrmann K, Reinhardt HC, Rassaf T, Kleinschnitz C, Hagenacker T, Stettner M. Thimm A, et al. Among authors: kleinschnitz c. J Neurol. 2023 Jul;270(7):3483-3491. doi: 10.1007/s00415-023-11689-z. Epub 2023 Apr 4. J Neurol. 2023. PMID: 37014422 Free PMC article.
Treatment of acute ischemic stroke in patients with active malignancy: insight from a comprehensive stroke center.
Chae WH, Vössing A, Li Y, Deuschl C, Milles LS, Kühne Escolà J, Hüsing A, Darkwah Oppong M, Dammann P, Glas M, Forsting M, Kleinschnitz C, Köhrmann M, Frank B. Chae WH, et al. Among authors: kleinschnitz c. Ther Adv Neurol Disord. 2023 Oct 31;16:17562864231207508. doi: 10.1177/17562864231207508. eCollection 2023. Ther Adv Neurol Disord. 2023. PMID: 37920861 Free PMC article.
Effectiveness and tolerability of eptinezumab in treating patients with migraine resistant to conventional preventive medications and CGRP (receptor) antibodies: a multicentre retrospective real-world analysis from Germany.
Scheffler A, Wenzel P, Bendig M, Gendolla A, Basten J, Kleinschnitz C, Nsaka M, Lindner D, Naegel S, Burow P, Fleischmann R, Holle D. Scheffler A, et al. Among authors: kleinschnitz c. J Headache Pain. 2024 May 16;25(1):79. doi: 10.1186/s10194-024-01788-1. J Headache Pain. 2024. PMID: 38755541 Free PMC article.
[Consensus recommendations on regional interdisciplinary standardization of MRI diagnostics for multiple sclerosis in the metropolitan area of Essen].
Stettner M, Wattjes MP, Krüger K, Pul R, Fleischer M, Achnitz U, Agne H, Bach K, Berkenfeld R, Bongartz U, Brüggemann A, Burgsmüller L, Cohnen J, Deuschl C, Friedrich A, Graziano P, Hackert J, Hapig B, Henkel A, Henrich H, Hükelheim-Görden M, Kratsch L, Kytzia D, Lanzman R, Heusch P, Laufenburg C, Merguet S, Metz U, Montag M, Obeid M, Ornek A, Peters S, Plajer T, Plassmann J, Pump H, Rauchfuss-Hartych B, Reinboldt MP, Seng K, Stauder M, Wettig AK, Wolters A, Yilmam S, Kleinschnitz C. Stettner M, et al. Among authors: kleinschnitz c. Nervenarzt. 2023 Dec;94(12):1123-1128. doi: 10.1007/s00115-023-01531-2. Epub 2023 Aug 18. Nervenarzt. 2023. PMID: 37594495 Free PMC article. Review. German.
Long-term efficacy and safety of nusinersen in adults with 5q spinal muscular atrophy: a prospective European multinational observational study.
Günther R, Wurster CD, Brakemeier S, Osmanovic A, Schreiber-Katz O, Petri S, Uzelac Z, Hiebeler M, Thiele S, Walter MC, Weiler M, Kessler T, Freigang M, Lapp HS, Cordts I, Lingor P, Deschauer M, Hahn A, Martakis K, Steinbach R, Ilse B, Rödiger A, Bellut J, Nentwich J, Zeller D, Muhandes MT, Baum T, Christoph Koch J, Schrank B, Fischer S, Hermann A, Kamm C, Naegel S, Mensch A, Weber M, Neuwirth C, Lehmann HC, Wunderlich G, Stadler C, Tomforde M, George A, Groß M, Pechmann A, Kirschner J, Türk M, Schimmel M, Bernert G, Martin P, Rauscher C, Meyer Zu Hörste G, Baum P, Löscher W, Flotats-Bastardas M, Köhler C, Probst-Schendzielorz K, Goldbach S, Schara-Schmidt U, Müller-Felber W, Lochmüller H, von Velsen O; SMArtCARE Study Group; Kleinschnitz C, Ludolph AC, Hagenacker T. Günther R, et al. Among authors: kleinschnitz c. Lancet Reg Health Eur. 2024 Feb 6;39:100862. doi: 10.1016/j.lanepe.2024.100862. eCollection 2024 Apr. Lancet Reg Health Eur. 2024. PMID: 38361750 Free PMC article.
Acceptance, drivers, and barriers to use eHealth interventions in patients with post-COVID-19 syndrome for management of post-COVID-19 symptoms: a cross-sectional study.
Schröder J, Bäuerle A, Jahre LM, Skoda EM, Stettner M, Kleinschnitz C, Teufel M, Dinse H. Schröder J, et al. Among authors: kleinschnitz c. Ther Adv Neurol Disord. 2023 May 27;16:17562864231175730. doi: 10.1177/17562864231175730. eCollection 2023. Ther Adv Neurol Disord. 2023. PMID: 37255668 Free PMC article.
489 results